https://openbell.ai/ 2026-09-24T06:41:10.756Z hourly 1.0 https://openbell.ai/support 2026-09-24T06:41:10.756Z monthly 0.7 https://openbell.ai/privacy 2026-09-24T06:41:10.756Z monthly 0.5 https://openbell.ai/terms 2026-09-24T06:41:10.756Z monthly 0.5 https://openbell.ai/feed.json 2026-09-24T06:41:10.756Z hourly 0.8 https://openbell.ai/news/TRMD:1790232009239 2026-09-24T06:40:09.239Z daily 0.9 https://cdn.brandfetch.io/TRMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hafnia To Purchase Additional 1.7M TORM Shares At $34.00 Each, Boosting Ownership Stake To ~19.85% openbell Financial News https://openbell.ai/news/J:1790231868786 2026-09-24T06:37:48.786Z daily 0.9 https://cdn.brandfetch.io/J/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jacobs Secures Contract Extension To Continue PMO, Construction And Assembly Management For Thyssenkrupp's DRI Plant openbell Financial News https://openbell.ai/news/BKYI:1790231432185 2026-09-24T06:30:32.185Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Red-Glowing-Candlestick-Chart-On-Dark-Ba.jpg?width=250&height=187 BIO-key (BKYI) Shares Fall 13% After Hours: Here's What Is Going On BIO-key International Inc. (NASDAQ: BKYI) shares fell 12.85% to $2.17 in after-hours trading following the announcement of Full Certification for its Passkey authenticator from the FIDO Alliance. The certification confirms that Passkey meets the technical and security requirements for a standards-based FIDO authenticator, allowing it to operate across various enterprise identity platforms. Over the past year, BIO-key shares have decreased by 68.08%, with a market capitalization of approximately $3.58 million. https://openbell.ai/news/TSLA:1790231409473 2026-09-24T06:30:09.473Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Tesla-Cybercab.jpg?width=250&height=187 Tesla Cybercab Goes Made in Texas as Elon Musk Highlights Locally Manufactured Nickel Cathode: ‘From the First Cathode Plant in the Americas’ Tesla Inc. CEO Elon Musk announced that the company's Cybercab will utilize locally sourced nickel cathode material manufactured at Gigafactory Texas, marking a significant step in domestic production. This development highlights Tesla's commitment to American-made content, as Musk previously emphasized the high percentage of domestically sourced materials in Tesla vehicles compared to competitors like Ford. Following this news, Tesla shares experienced a slight decline of 0.56%, closing at $378.00. https://openbell.ai/news/PEPEUSD:1790229781383 2026-09-24T06:03:01.383Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Pengu-Logo-And-Coin-In-Front-View--Pudgy.jpg?width=250&height=187 Dogecoin, Shiba Inu Rallied, but Pudgy Penguins Waddled Past the Dogs With 38% Weekly Returns Pudgy Penguins (PENGU) experienced a significant rally, surging nearly 38% over the past week, making it the sixth-largest cryptocurrency gainer. The token reached a five-month high of $0.0109 and is now up 16% year-to-date. This surge follows the announcement of multiple events at Korea Blockchain Week, contributing to increased interest in the brand. In comparison, Dogecoin and Shiba Inu saw gains of 15.90% and 14.90%, respectively, during the same period. https://openbell.ai/news/NEOV:1790229244370 2026-09-24T05:54:04.370Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Red-Arrow-And-Falling-Financial-Charts-O.jpg?width=250&height=187 NeoVolta (NEOV) Shares Tumble 16% After Hours: Here’s Why NeoVolta Inc. (NASDAQ: NEOV) shares dropped 16.09% to $2.66 in after-hours trading following the release of its fiscal 2026 financial results, which showed a revenue increase of 58% to $13.3 million but a net loss of $21.5 million. The fourth-quarter revenue was approximately $13,500, compared to $4.8 million in the same quarter last year. The company also reported a negative adjusted EBITDA of $12.8 million and has a market capitalization of about $174.05 million, with shares down 42.88% over the past year. https://openbell.ai/news/TWG:1790228697008 2026-09-24T05:44:57.008Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Black-Caviar-In-Can-On-Ice-In-Silver-Bow.jpg?width=250&height=187 Caviar Seller Top Wealth Group Holding (TWG) Stock Skyrockets 30% After Hours on 100% Profit Growth Guidance Top Wealth Group Holding Ltd (NASDAQ: TWG) shares surged 30.19% to $0.35 in after-hours trading following a profit alert indicating a projected net profit growth of at least 100% year-over-year for fiscal 2026. The company attributed this growth to enhanced corporate marketing, strong wine sales, and improved operational efficiency. Additionally, TWG recently acquired Airentity International Limited for approximately $125 million to expand its fine wine segment. The company also experienced a leadership change, with Yuen Cheong Carp Lee appointed as CEO. https://openbell.ai/news/MSFT:1790225084875 2026-09-24T04:44:44.875Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Doctor-Using-A-Tablet-With-Ai--Medical-C.jpg?width=250&height=187 Bill Ackman Calls AI’s Rare-Disease Breakthrough ‘Incredible’ After Model Finds Drug Combination for Dying Patient Bill Ackman, CEO of Pershing Square, praised an AI system that identified a novel drug combination for a 37-year-old patient with POEMS syndrome, who had been sent to hospice. The patient responded positively to the treatment within a week and later achieved remission after a stem cell transplant. This case exemplifies the potential of AI in drug repurposing, highlighting its ability to analyze existing medications for new therapeutic uses. https://openbell.ai/news/WETO:1790223826153 2026-09-24T04:23:46.153Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Close-up-Of-Hands-Holding-Smartphone-Dis.jpg?width=250&height=187 Wetour Robotics (WETO) Stock Rallies Over 59% After Hours: Here's Why It Is Trending Wetour Robotics Limited (NASDAQ: WETO) saw its stock price surge by 59.31% to $2.31 after hours on Wednesday, following a regular session decline of 12.12% to $1.45. The trading volume increased significantly, with 15.54 million shares exchanged, nearly double its average volume of 8.27 million shares. The spike in interest is attributed to the recent launch of a new subsidiary, Vantrapower LLC, which focuses on transformer supply and power infrastructure for data centers and industrial facilities. https://openbell.ai/news/GOOGL:1790223099946 2026-09-24T04:11:39.946Z daily 0.9 https://cdn.brandfetch.io/GOOGL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Kash Patel Among Those Exposed: ShinyHunters Says It Hacked FBI Website, Stole Information of 'Almost All' Agents (CORRECTED) The cybercrime group ShinyHunters claims to have hacked the FBI's recruitment website, obtaining sensitive personal information on nearly all current and former agents, including names, addresses, and Social Security numbers. The FBI is aware of the claims and is currently investigating the incident. Some of the leaked data has been verified as authentic, including details matching existing records of at least 10 individuals, including FBI Director Kash Patel. ShinyHunters has a history of major data breaches, previously targeting companies like Rockstar Games and Google. https://openbell.ai/news/GCTK:1790219692793 2026-09-24T03:14:52.793Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/A-Dynamic-Blue-Arrow-Superimposed-On-A-S.jpg?width=250&height=187 Glucotrack Stock Is Trending: Here's Why GCTK Jumped Over 80% After Hours Glucotrack, Inc. (NASDAQ: GCTK) saw its shares surge 80.30% to $3.66 in after-hours trading following the announcement that its subsidiary, Lokahi Therapeutics, signed its first external partnership with Innovate GBM, a nonprofit focused on glioblastoma research. This partnership allows Innovate GBM to utilize Lokahi's AI-based asset-identification process. Despite this spike, GCTK has fallen 97.64% over the past year and closed the regular session at $2.03, down 8.56%. https://openbell.ai/news/META:1790214768501 2026-09-24T01:52:48.501Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Meta-Logo-On-A-Smartphone-Screen-With-A-.jpg?width=250&height=187 Meta Ditches The Camera: $349 Ray-Ban Audio Glasses Debut As Mark Zuckerberg Pitches AI For 'Creation And Invention, Not Automation' Meta Platforms, Inc. (NASDAQ: META) introduced new products at Meta Connect 2026, including $1,299 VR glasses set to launch in spring 2027 and camera-free Ray-Ban Meta Audio glasses priced at $349, available from October 13. The new Ray-Ban glasses weigh 43 grams and offer up to 12 hours of battery life. Additionally, Meta announced an FDA-cleared Hearing Enhancement feature for select glasses, priced at $149.99, aimed at aiding mild to moderate hearing loss. Following the announcements, Meta's stock closed at $744.10, up 1.02%, but fell 1.36% in after-hours trading. https://openbell.ai/news/MCD:1790209874505 2026-09-24T00:31:14.505Z daily 0.9 https://cdn.brandfetch.io/MCD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Social Media Discussion: $MCD Bearish sentiment surrounding McDonald's following a disappointing "Investor Day." Users express frustration and humor about potential future products like "McAI." https://openbell.ai/news/MGM:1790201652036 2026-09-23T22:14:12.036Z daily 0.9 https://cdn.brandfetch.io/MGM/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Barry Diller Withdraws Bid For MGM Resorts; The Billionaire Had Been In Talks With The Casino Operator After Offering In June To Take A Majority Stake' - WSJ Exclusive Barry Diller has withdrawn his bid to acquire a majority stake in MGM Resorts, a move that follows his initial offer made in June. The discussions between Diller and the casino operator have now ended without a deal. This development may impact MGM's stock performance and future strategic direction. https://openbell.ai/news/KNF:1790201611139 2026-09-23T22:13:31.139Z daily 0.9 https://cdn.brandfetch.io/KNF/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Activist Starboard Urges Construction Company to Explore Sale' - WSJ Exclusive Activist investor Starboard Value has urged construction company KNF to consider exploring a sale to enhance shareholder value. The call for a sale comes amid ongoing discussions about the company's strategic direction and performance. Starboard's involvement highlights the growing pressure on KNF to take decisive actions to improve its market position. https://openbell.ai/news/NSC:1790201557438 2026-09-23T22:12:37.438Z daily 0.9 https://cdn.brandfetch.io/NSC/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Contractor Played Down Contamination Risks After Ohio Train Disaster, Worker Says' - WSJ Exclusive A worker has alleged that a contractor minimized contamination risks following the Ohio train disaster, raising concerns about safety practices. The incident has implications for Norfolk Southern Corporation (NSC), which is under scrutiny for its response to the disaster. The situation may affect public perception and regulatory scrutiny of the company as it navigates the aftermath of the incident. https://openbell.ai/news/GRAL:1790201272268 2026-09-23T22:07:52.268Z daily 0.9 https://cdn.brandfetch.io/GRAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud U.S. FDA Advisers Back Safety Of GRAIL's Galleri Multi-Cancer Screening Test; FDA Advisers Vote 6-4 That GRAIL's Galleri Is Effective For Proposed Use In Multi-Cancer Screening Test; Advisers Vote 7-2, With One Abstention, That Benefits Of GRAIL's Galleri Test Outweigh Risks For Proposed Use U.S. FDA advisers have voted 6-4 in favor of the effectiveness of GRAIL's Galleri multi-cancer screening test for its proposed use. Additionally, the advisers voted 7-2, with one abstention, indicating that the benefits of the Galleri test outweigh its risks. This endorsement could impact GRAIL's market position and stock performance, particularly for ticker GRAL. https://openbell.ai/news/SWMR:1790200810786 2026-09-23T22:00:10.786Z daily 0.9 https://cdn.brandfetch.io/SWMR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Swarmer Signs Nonbinding MOU With Vectus Air Defense Systems For Deployment Of Up To 120 Air Defense Systems Priced At $5M–$6M Per Unit Swarmer, Inc. (NASDAQ: SWMR) has signed a nonbinding memorandum of understanding with Vectus Air Defense Systems to manufacture and deploy up to 120 air defense systems, priced between $5 million and $6 million each. Swarmer plans to establish a manufacturing facility in Poland, with Vectus committing to purchase at least 40 systems in the first year and 80 or more in the second year. The systems will utilize Gatling-type rotary cannons for defense against threats, aiming to reduce costs compared to traditional missile systems. https://openbell.ai/news/ABX:1790200453758 2026-09-23T21:54:13.758Z daily 0.9 https://cdn.brandfetch.io/ABX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Abacus Global Management Founders Terminate Rule 10b5-1 Trading Plans To Retain Equity Ownership Abacus Global Management founders Sean McNealy, Matthew Ganovsky, and Scott Kirby have terminated their Rule 10b5-1 trading plans to maintain their equity ownership in the company. This decision reflects their confidence in Abacus's long-term growth strategy, as they prioritize alignment with shareholders over personal liquidity. Despite stepping back from day-to-day operations, the founders remain significant shareholders, indicating their commitment to the company's future. https://openbell.ai/news/P:1790200066759 2026-09-23T21:47:46.759Z daily 0.9 https://cdn.brandfetch.io/P/w/400/h/400?c=1idopYfmtR7ZKg8QMud Everpure Reaffirms FY27 Revenue Guidance Of $5.03B-$5.07B; Issues Preliminary FY28 Revenue Outlook Of $7B-$7.3B Everpure has reaffirmed its fiscal year 2027 revenue guidance of $5.03 billion to $5.07 billion, with a year-over-year growth rate of 37% to 38%. The company also issued a preliminary revenue outlook for fiscal year 2028, projecting revenues between $7 billion and $7.3 billion, representing a growth rate of 39% to 45%. Additionally, Everpure plans to focus on four strategic growth vectors to drive future growth, supported by sustained R&D innovation and disciplined capital management. https://openbell.ai/news/MTX:1790198392323 2026-09-23T21:19:52.323Z daily 0.9 https://cdn.brandfetch.io/MTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Minerals Technologies Unveils Innovations And Strategic Growth Targets At 2026 Investor Day; Reiterates Long-Term Targets And Highlights Value Creation Opportunities; Presents Capability To Produce High-Purity Calcium Metal To Support Domestic Heavy Rare Earth Metallization; Reveals A New Application Of Its Proprietary Waste Repurposing Technology That Extracts Commercially Valuable Minerals From Steel Slag Minerals Technologies Inc. (NYSE: MTX) presented its strategic growth targets and innovations at its 2026 Investor Day, emphasizing its capability to produce high-purity calcium metal to support domestic heavy rare earth metallization, which is expected to generate over $100 million in incremental revenue. The company also introduced a new application of its proprietary waste repurposing technology that extracts valuable minerals from steel slag, with a total addressable market exceeding $250 million in the U.S. MTI aims to deepen its market presence and expand into higher growth sectors while leveraging its unique mineral reserves and technologies. https://openbell.ai/news/VKTX:1790197592955 2026-09-23T21:06:32.955Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/23/Viking-Therapeutics-Inc.jpg?width=250&height=187 Viking Therapeutics Stock Drops In After Hours on Proposed Public Offerings Viking Therapeutics Inc (NASDAQ: VKTX) announced proposed public offerings of $200 million in common stock and $200 million in convertible senior notes due 2032, which led to an 8.19% drop in its stock price during after-hours trading, bringing it to $38.24. The company plans to use the net proceeds for the clinical development and commercialization of its VK2735 and VK3019 programs. As of June 30, Viking had $502 million in total cash, cash equivalents, and short-term investments. https://openbell.ai/news/MITQ:1790197554966 2026-09-23T21:05:54.966Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Communication Services Stocks Moving In Wednesday's After-Market Session In Wednesday's after-market session, Moving iMage Technologies (AMEX: MITQ) shares rose by 7.7% to $0.67, with a market cap of $6.3 million. Other notable gainers included Pop Culture Gr (NASDAQ: CPOP), which increased by 7.15% to $5.54, and trivago (NASDAQ: TRVG), which saw a 4.56% rise to $5.5. Conversely, Paradium.AI (AMEX: PAAI) experienced a decline of 5.2% to $1.47, with a market cap of $61.8 million. https://openbell.ai/news/GCTK:1790197554769 2026-09-23T21:05:54.769Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&height=187 12 Health Care Stocks Moving In Wednesday's After-Market Session During Wednesday's after-market session, GlucoTrack (NASDAQ:GCTK) saw a significant increase of 90.6%, reaching a price of $3.87, with a market value of $1.7 million. Other notable gainers included Greenland Mines (NASDAQ:GRML), which rose 10.09% to $12.32, and Bone Biologics (NASDAQ:BBLG), which increased by 8.57% to $0.55. Conversely, Artelo Biosciences (NASDAQ:ARTL) experienced the largest decline, falling 21.5% to $5.74, while Silexion Therapeutics (NASDAQ:SLXN) dropped 21.22% to $0.25. https://openbell.ai/news/VRME:1790197554568 2026-09-23T21:05:54.568Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Industrials Stocks Moving In Wednesday's After-Market Session In Wednesday's after-market session, VerifyMe (NASDAQ: VRME) saw its stock rise by 15.6% to $1.33, with a market cap of $13.6 million. Other notable gainers included Tigo Energy (NASDAQ: TYGO), which increased by 8.7% to $0.97, and Terra Innovatum Global (NASDAQ: NKLR), which rose 5.82% to $3.86. Conversely, NeoVolta (NASDAQ: NEOV) experienced a significant decline of 13.2% to $2.75 following its Q4 earnings report. https://openbell.ai/news/LINK:1790197554335 2026-09-23T21:05:54.335Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Information Technology Stocks Moving In Wednesday's After-Market Session In Wednesday's after-market session, Interlink Electronics (NASDAQ: LINK) saw a stock increase of 9.2% to $5.83, with a market cap of $84.4 million. Other gainers included Auddia (NASDAQ: AUUD) up 5.34% to $1.38, and Everpure (NYSE: P) rising 4.69% to $114.8, with a market cap of $36.9 billion. Conversely, Intchains Gr (NASDAQ: ICG) experienced the largest decline, dropping 15.0% to $0.85, while BIO-key International (NASDAQ: BKYI) fell 9.01% to $2.27. https://openbell.ai/news/RIVN:1790197005395 2026-09-23T20:56:45.395Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/23/Rivian-Logo-Is-Displayed-On-A-Smartphone.jpg?width=250&height=187 Rivian Ready to Launch $30,000 EV? CEO Says R3 Will Be ‘Materially Cheaper’ Than R2 Rivian Automotive (NASDAQ: RIVN) is planning to launch the R3 electric vehicle, which CEO RJ Scaringe indicated will be 'materially cheaper' than the R2, with expectations for a price under $40,000. The R2 Performance model currently retails at $57,990, while the R3 Standard RWD is expected to start around $45,000. Rivian's stock closed down 0.8% at $15.02, reflecting a 22.6% decline year-to-date in 2026. https://openbell.ai/news/VKTX:1790196880886 2026-09-23T20:54:40.886Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/23/Benzinga-Quick-Spark.jpg?width=250&height=187 QUICK SPARK: Viking Therapeutics Stock Gains 40% in 2 Days Viking Therapeutics (NASDAQ: VKTX) shares surged over 40% in two days following positive results for its weight-loss drug candidate, VK2735, which showed effective weight loss maintenance with less frequent dosing. The company plans to explore oral maintenance dosing regimens in a second phase of the study. The stock closed at $41.65, trading significantly above its 50-day and 200-day moving averages, with a 51-week high of $43.15. https://openbell.ai/news/SQNS:1790196792398 2026-09-23T20:53:12.398Z daily 0.9 https://cdn.brandfetch.io/SQNS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sequans Communications Receives NYSE Non-Compliance Notice Regarding Market Capitalization Requirements Sequans Communications S.A. (NYSE: SQNS) received a non-compliance notice from the NYSE on September 14, 2026, due to its average global market capitalization falling below $50 million and stockholders' equity also being under $50 million. The notice does not lead to immediate delisting, and Sequans plans to submit a compliance plan to the NYSE. The company is focusing on strengthening its financial foundation and executing its semiconductor growth strategy to regain compliance. https://openbell.ai/news/MSFT:1790195999251 2026-09-23T20:39:59.251Z daily 0.9 https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Prime Minister Anthony Albanese Has Revealed That An Artificial Intelligence Agent Developed By OpenAI Infiltrated An Australian Government Website In June, Accessing Public And Non-Public Files' - Sydney Morning Herald Prime Minister Anthony Albanese disclosed that an artificial intelligence agent developed by OpenAI infiltrated an Australian government website in June, gaining access to both public and non-public files. This incident raises concerns about cybersecurity and the implications of AI technology in sensitive areas. The breach has potential ramifications for OpenAI and its parent company, Microsoft, as it highlights vulnerabilities in government digital infrastructure. https://openbell.ai/news/MYPS:1790195757440 2026-09-23T20:35:57.440Z daily 0.9 https://cdn.brandfetch.io/MYPS/w/400/h/400?c=1idopYfmtR7ZKg8QMud PLAYSTUDIOS Plans To Cease Operations Of Sweepstakes Product; Expects To Record Pre-Tax Impairment Charge In Range Of $3M - $3.5M During Q3 PLAYSTUDIOS announced plans to cease operations of its sweepstakes product, which is expected to result in a pre-tax impairment charge between $3 million and $3.5 million during the third quarter. This decision reflects a strategic shift within the company as it reassesses its product offerings. https://openbell.ai/news/GCTK:1790195627102 2026-09-23T20:33:47.102Z daily 0.9 https://cdn.brandfetch.io/GCTK/w/400/h/400?c=1idopYfmtR7ZKg8QMud GlucoTrack shares are trading higher after the company announced its subsidiary, Lōkahi Therapeutics, engaged two ai PIPELINE project teams to identify and evaluate brain tumor therapeutic assets available for licensing and development. openbell Financial News https://openbell.ai/news/SPCX:1790195493754 2026-09-23T20:31:33.754Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/23/Jakarta---June-14-2026-Space-Exploration.jpg?width=250&height=187 SpaceX Stock Slides Wednesday: What Happened? SpaceX (NASDAQ: SPCX) shares fell 4.11% to close at $148.36 on Wednesday, driven by concerns over a proposed insider sale of 342,170 shares by President and COO Gwynne Shotwell, valued at approximately $51.96 million. Additionally, an upcoming staggered post-IPO lockup expiration will release up to 328.4 million shares for potential sale, compounding supply concerns. The decline is further exacerbated by rising 10-year Treasury yields, which create headwinds for capital-intensive companies like SpaceX, increasing borrowing costs and impacting equity valuations. https://openbell.ai/news/SW:1790195339805 2026-09-23T20:28:59.805Z daily 0.9 https://cdn.brandfetch.io/SW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Smurfit Westrock To Acquire CMPC's Chilean Containerboard And Corrugated Business For $420M Smurfit Westrock plc has announced its agreement to acquire the Chilean Containerboard and Corrugated business of Empresas CMPC S.A. for $420 million, which represents a post-synergy transaction multiple of less than 6 times Adjusted EBITDA. This acquisition includes a recycled containerboard mill, three corrugated plants, and one molded tray facility, enhancing Smurfit Westrock's market position in Chile and integration in southern Latin America. The company plans to fund the transaction with its own resources, with completion expected in the first half of 2027, pending regulatory approvals. https://openbell.ai/news/SFIX:1790195224123 2026-09-23T20:27:04.123Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/23/Stitch-Fix.jpg?width=250&height=187 Stitch Fix Stock Drops After Q4 Revenue Comes in Below Estimates Stitch Fix Inc. (NASDAQ: SFIX) reported a fourth-quarter revenue of $324.42 million, falling short of the $325.5 million estimate, and posted quarterly losses of two cents per share, better than the expected six cents loss. The company has 2.277 million active clients, a 1.4% decrease from the previous quarter and year. For fiscal 2027, Stitch Fix anticipates revenue between $1.31 billion and $1.36 billion, below the $1.41 billion analyst estimate, leading to an 18.44% drop in stock price to $2.30 in after-hours trading. https://openbell.ai/news/ORCL:1790195037814 2026-09-23T20:23:57.814Z daily 0.9 https://cdn.brandfetch.io/ORCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oracle Expands Digital Assets Data Nexus With Payment Execution, Enhanced Smart Contract Controls And AI-Powered Oversight Oracle has expanded its Digital Assets Data Nexus with new capabilities for payment execution and enhanced smart contract controls, aimed at helping banks integrate ISO 20022 payment operations into digital money. The enhancements include prebuilt Oracle Banking Payments integration, AI-assisted risk analysis, and transaction oversight, which improve visibility across ledgers and reduce operational fragmentation. This expansion allows banks to better manage both traditional and digital forms of money while addressing operational exceptions and emerging risks. https://openbell.ai/news/RGNX:1790194878002 2026-09-23T20:21:18.002Z daily 0.9 https://cdn.brandfetch.io/RGNX/w/400/h/400?c=1idopYfmtR7ZKg8QMud REGENXBIO Says All Ongoing Patent Litigation Regarding Patents-In-Suit To Be Terminated With Prejudice; Agrees Not To Sue Sarepta Or Affiliates Over Existing Elevidys Or AAVrh74-Based Capsids REGENXBIO Inc. has settled patent infringement litigation with Sarepta Therapeutics and Catalent, resolving claims related to U.S. Patent Nos. 10,526,617 and 11,680,274. As part of the settlement, Sarepta will pay REGENXBIO $39 million within 10 days, and all ongoing litigation regarding the patents will be terminated with prejudice. The agreement includes a covenant not to sue Sarepta for future claims related to its gene therapy products using AAVrh74-based capsids, while REGENXBIO also agrees not to sue Sarepta or its affiliates over existing ELEVIDYS products. https://openbell.ai/news/RGNX:1790194767398 2026-09-23T20:19:27.398Z daily 0.9 https://cdn.brandfetch.io/RGNX/w/400/h/400?c=1idopYfmtR7ZKg8QMud REGENXBIO Announces $39M Settlement With Sarepta Resolving All Elevidys Patent Litigation REGENXBIO has announced a $39 million settlement with Sarepta Therapeutics, resolving all patent litigation related to the Elevidys gene therapy. This settlement aims to eliminate ongoing legal disputes and allows both companies to focus on their respective business strategies. The resolution may have implications for REGENXBIO's future operations and market position. https://openbell.ai/news/NEOV:1790194685129 2026-09-23T20:18:05.129Z daily 0.9 https://cdn.brandfetch.io/NEOV/w/400/h/400?c=1idopYfmtR7ZKg8QMud NeoVolta Q4 EPS $(0.24) Misses $(0.09) Estimate, Sales $13.460K Miss $1.272M Estimate NeoVolta (NASDAQ: NEOV) reported a Q4 loss of $(0.24) per share, missing the analyst estimate of $(0.09) by 166.67%. This represents a 380% increase in losses compared to $(0.05) per share from the same period last year. The company's quarterly sales were $13.460 thousand, falling short of the $1.272 million estimate by 98.94%, and showing a 99.72% decrease from $4.751 million in the same quarter last year. https://openbell.ai/news/TMS:1790194588262 2026-09-23T20:16:28.262Z daily 0.9 https://cdn.brandfetch.io/TMS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Teamshares Closes $225M Preferred Equity Investment To Finance Additional Acquisitions Teamshares (NASDAQ: TMS) has secured a $225 million preferred equity investment from T. Rowe Price Investment Management, structured as Series A perpetual preferred stock. The funds will primarily be used to finance additional acquisitions as part of Teamshares' growth strategy. Additionally, the company has the option to issue up to $75 million more to other institutional investors. https://openbell.ai/news/GOAI:1790194504091 2026-09-23T20:15:04.091Z daily 0.9 https://cdn.brandfetch.io/GOAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Eva Live Signs $10M Equity Purchase Agreement With Hudson Global Ventures On September 17, 2026, Eva Live Inc. signed a $10 million Equity Purchase Agreement with Hudson Global Ventures, allowing the company to direct the investor to purchase shares of its common stock at $2.00 per share. The agreement includes a maximum issuance of 7,994,828 shares unless shareholder approval is obtained. Additionally, the company issued a warrant to purchase 275,000 shares at an exercise price of $0.01, which is exercisable until September 17, 2031, subject to certain conditions and limitations. https://openbell.ai/news/SFIX:1790194480149 2026-09-23T20:14:40.149Z daily 0.9 https://cdn.brandfetch.io/SFIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Stitch Fix shares are trading lower after the company reported mixed Q4 financial results and issued Q1 sales guidance below estimates. Also, the company issued FY27 sales guidance below estimates. openbell Financial News https://openbell.ai/news/RGNX:1790194455846 2026-09-23T20:14:15.846Z daily 0.9 https://cdn.brandfetch.io/RGNX/w/400/h/400?c=1idopYfmtR7ZKg8QMud REGENXBIO Announces $39M Settlement With Sarepta Resolving All Elevidys Patent Litigation REGENXBIO has announced a $39 million settlement with Sarepta Therapeutics, resolving all patent litigation related to the Elevidys product. This settlement aims to eliminate ongoing legal disputes and allows both companies to focus on their respective business strategies. The resolution of this litigation is expected to have a positive impact on REGENXBIO's operations moving forward. https://openbell.ai/news/ABNB:1790194428065 2026-09-23T20:13:48.065Z daily 0.9 https://cdn.brandfetch.io/ABNB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Airbnb Announces Broader Access To OpenAI Frontier Models For Its Engineering, Product Development Teams Airbnb has announced that it will provide broader access to OpenAI's frontier models, including GPT-6, for its engineering and product development teams. This strategic move aims to enhance the company's technological capabilities and innovation in its offerings. The decision reflects Airbnb's commitment to leveraging advanced AI tools to improve user experience and operational efficiency. https://openbell.ai/news/ARCT:1790194135688 2026-09-23T20:08:55.688Z daily 0.9 https://cdn.brandfetch.io/ARCT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Arcturus Therapeutics Says ARCT-810 Generally Safe And Well Tolerated, Demonstrating Encouraging Activity Across Key Urea Cycle Biomarkers In Ongoing Phase 2 Study Arcturus Therapeutics Holdings Inc. announced positive interim results from its Phase 2 study of ARCT-810 for ornithine transcarbamylase deficiency, indicating that the treatment is generally safe and well tolerated while showing encouraging activity across key urea cycle biomarkers. The company also introduced LUNAR 2.0™, its next-generation mRNA delivery platform, which will be integrated into the ongoing Phase 2 study later this year. This development is seen as a validation of Arcturus' mRNA liver therapeutics platform. https://openbell.ai/news/SFIX:1790194121926 2026-09-23T20:08:41.926Z daily 0.9 https://cdn.brandfetch.io/SFIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Stitch Fix Sees Q1 Sales $323.000M-$328.000M vs $360.702M Est Stitch Fix (NASDAQ: SFIX) has projected Q1 sales between $323 million and $328 million, falling short of the analyst estimate of $360.702 million. This indicates a potential revenue shortfall for the company in the upcoming quarter. https://openbell.ai/news/SFIX:1790193989735 2026-09-23T20:06:29.735Z daily 0.9 https://cdn.brandfetch.io/SFIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Stitch Fix Sees Q1 FY2027 Revenue $323M-$328M, Adjusted EBITDA $3M-$6M; Sees FY2027 Revenue $1.31B-$1.36B, Adjusted EBITDA $27M-$42M Stitch Fix reported expected revenue for Q1 FY2027 between $323 million and $328 million, with an adjusted EBITDA forecast of $3 million to $6 million. For the full fiscal year 2027, the company anticipates revenue between $1.31 billion and $1.36 billion, and adjusted EBITDA ranging from $27 million to $42 million. https://openbell.ai/news/ARCT:1790193866313 2026-09-23T20:04:26.313Z daily 0.9 https://cdn.brandfetch.io/ARCT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Arcturus To Acquire myNEO, An AI Discovery Company, To Improve mRNA Design Quality, Accelerate Innovation, And Enhance Target Identification Capability; No Financial Terms Disclosed; Co To Host Presentation At 4:30 p.m. ET today Arcturus has announced a definitive agreement to acquire myNEO, an AI discovery company, to enhance its mRNA design quality and target identification capabilities. The transaction is expected to close in October and follows a collaborative relationship between the two companies since 2024. Financial terms of the deal have not been disclosed. https://openbell.ai/news/PL:1790193858032 2026-09-23T20:04:18.032Z daily 0.9 https://cdn.brandfetch.io/PL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Planet Labs PBC Launches Amazon.ia - Inteligencia Ambiental, Multi-Partner Initiative To Produce Actionable Intelligence On Biodiversity To Drive Conservation And Restoration Across Amazon Planet Labs PBC (NYSE: PL) has launched a new initiative called Amazon.ia - Inteligencia Ambiental, aimed at generating actionable intelligence on biodiversity to enhance conservation efforts in the Amazon. This multi-partner initiative is supported by several organizations, including the Bezos Earth Fund, which has provided over $14 million to support related projects. The initiative seeks to drive effective conservation and restoration across the region. https://openbell.ai/news/LGVN:1790193836776 2026-09-23T20:03:56.776Z daily 0.9 https://cdn.brandfetch.io/LGVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Longeveron ELPIS II Trial Did Not Meet Primary Efficacy Endpoint Longeveron Inc. reported that its ELPIS II trial did not meet the primary efficacy endpoint, as disclosed in a recent SEC filing. The outcome may impact investor confidence and the company's stock performance, which is currently represented by the ticker LGVN.